Plateletcrit

There are 11 papers on plateletcrit in aging research: 11 observational studies in people.

Biomarker

11 papers study it2 more mention it4 findings

1 new paper in 30 daysSee all 13 papers on plateletcrit

“PCT and PDW showed relatively stronger associations with MetS (PCT: Q4 vs Q1, aOR = 1.85, 95% CI: 1.81-1.89;”
Association Between Platelet Parameters and Metabolic Syndrome in Residents of Wuhu, China: A Mediation Analysis of Insulin ResistanceDiabetes, metabolic syndrome and obesity : targets and therapy2026doi:10.2147/dmso.s575645
  • Humans11

Effects

1

Telomere length

mediatesin humans1

1 study
  1. Plateletcrit is linked with telomere length in humans (association between central obesity indices and aging biomarkers) (2.85% to 10.10%).

    Humansassociation between central obesity indices and aging biomarkersn = 5,091

More on Telomere length

Associations

3

Motoric cognitive risk syndrome

upin humans1OR 1.13

1 study
  1. Plateletcrit is associated with motoric cognitive risk syndrome in humans after adjustment for potential confounders (OR 1.13, 95% CI 1.01 to 1.26).

    Humansafter adjustment for potential confoundersn = 4,080

More on Motoric cognitive risk syndrome

Metabolic syndrome

upin humans1

1 study
  1. Plateletcrit is associated with metabolic syndrome in humans (Q4 versus Q1; multivariable adjusted) (aOR 1.85, 95% CI 1.81–1.89; Q4 versus Q1).

    HumansQ4 versus Q1; multivariable adjustedn = 570,000

More on Metabolic syndrome

Hepatocellular carcinoma

downin humans1OR 0.57

1 study
  1. Plateletcrit is linked with a lower risk of hepatocellular carcinoma in humans (conditional logistic regression with matched controls) (OR 0.57 (95% CI 0.42–0.78)).

    Humansconditional logistic regression with matched controls

More on Hepatocellular carcinoma

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 1Mar 2026: 1Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 1Nov 2026: 15 papers in 12 months

See all 13 papers on plateletcrit